The North America blood coagulation factor market is expanding with increasing awareness and diagnosis of inherited bleeding disorders and greater adoption of modern replacement therapies. Strong healthcare infrastructure, specialized hemophilia treatment centers, advances in recombinant products, and ongoing development of innovative therapies are supporting regional demand. Growing emphasis...